Global Human Coagulation Factor VIII Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

August 2018 | 133 pages | ID: GA2195A1494EN
GlobalInfoResearch

Abstracts

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.

Scope of the Report:

This report focuses on the Human Coagulation Factor VIII in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.

The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.

Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.

Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.

Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.

The worldwide market for Human Coagulation Factor VIII is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 8770 million US$ in 2023, from 7440 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Shire (Baxter)
• Bayer
• CSL
• Pfizer
• Grifols
• Biogen
• Octapharma
• NovoNordisk
• Greencross
• Kedrion
• BPL
• Hualan Bio
• RAAS

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Recombinant Factor VIII
• Plasma-derived Factor VIII

Market Segment by Applications, can be divided into

• Hemophilia A
• Spontanous / Trauma
• Surgical
• Other

There are 15 Chapters to deeply display the global Human Coagulation Factor VIII market.
Chapter 1, to describe Human Coagulation Factor VIII Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Coagulation Factor VIII, with sales, revenue, and price of Human Coagulation Factor VIII, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Coagulation Factor VIII, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Coagulation Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Coagulation Factor VIII sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Human Coagulation Factor VIII Introduction
1.2 Market Analysis by Type
  1.2.1 Recombinant Factor VIII
  1.2.2 Plasma-derived Factor VIII
1.3 Market Analysis by Applications
  1.3.1 Hemophilia A
  1.3.2 Spontanous / Trauma
  1.3.3 Surgical
  1.3.4 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Shire (Baxter)
  2.1.1 Business Overview
  2.1.2 Human Coagulation Factor VIII Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
  2.2.1 Business Overview
  2.2.2 Human Coagulation Factor VIII Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
  2.3.1 Business Overview
  2.3.2 Human Coagulation Factor VIII Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Human Coagulation Factor VIII Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Grifols
  2.5.1 Business Overview
  2.5.2 Human Coagulation Factor VIII Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biogen
  2.6.1 Business Overview
  2.6.2 Human Coagulation Factor VIII Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Octapharma
  2.7.1 Business Overview
  2.7.2 Human Coagulation Factor VIII Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 NovoNordisk
  2.8.1 Business Overview
  2.8.2 Human Coagulation Factor VIII Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Greencross
  2.9.1 Business Overview
  2.9.2 Human Coagulation Factor VIII Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Kedrion
  2.10.1 Business Overview
  2.10.2 Human Coagulation Factor VIII Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 BPL
  2.11.1 Business Overview
  2.11.2 Human Coagulation Factor VIII Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hualan Bio
  2.12.1 Business Overview
  2.12.2 Human Coagulation Factor VIII Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 RAAS
  2.13.1 Business Overview
  2.13.2 Human Coagulation Factor VIII Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HUMAN COAGULATION FACTOR VIII SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Human Coagulation Factor VIII Manufacturer Market Share in 2017
  3.3.2 Top 6 Human Coagulation Factor VIII Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET ANALYSIS BY REGIONS

4.1 Global Human Coagulation Factor VIII Sales, Revenue and Market Share by Regions
  4.1.1 Global Human Coagulation Factor VIII Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Human Coagulation Factor VIII Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
4.3 Europe Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
4.5 South America Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)

5 NORTH AMERICA HUMAN COAGULATION FACTOR VIII BY COUNTRIES

5.1 North America Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries
  5.1.1 North America Human Coagulation Factor VIII Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Human Coagulation Factor VIII Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
5.3 Canada Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
5.4 Mexico Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)

6 EUROPE HUMAN COAGULATION FACTOR VIII BY COUNTRIES

6.1 Europe Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries
  6.1.1 Europe Human Coagulation Factor VIII Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Human Coagulation Factor VIII Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
6.3 UK Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
6.4 France Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
6.5 Russia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
6.6 Italy Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC HUMAN COAGULATION FACTOR VIII BY COUNTRIES

7.1 Asia-Pacific Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Human Coagulation Factor VIII Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Human Coagulation Factor VIII Revenue and Market Share by Countries (2013-2018)
7.2 China Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
7.3 Japan Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
7.4 Korea Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
7.5 India Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA HUMAN COAGULATION FACTOR VIII BY COUNTRIES

8.1 South America Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries
  8.1.1 South America Human Coagulation Factor VIII Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Human Coagulation Factor VIII Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
8.3 Argentina Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
8.4 Colombia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA HUMAN COAGULATION FACTOR VIII BY COUNTRIES

9.1 Middle East and Africa Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Human Coagulation Factor VIII Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Human Coagulation Factor VIII Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
9.3 UAE Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
9.4 Egypt Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
9.6 South Africa Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)

10 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET SEGMENT BY TYPE

10.1 Global Human Coagulation Factor VIII Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
  10.1.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2013-2018)
10.2 Recombinant Factor VIII Sales Growth and Price
  10.2.1 Global Recombinant Factor VIII Sales Growth (2013-2018)
  10.2.2 Global Recombinant Factor VIII Price (2013-2018)
10.3 Plasma-derived Factor VIII Sales Growth and Price
  10.3.1 Global Plasma-derived Factor VIII Sales Growth (2013-2018)
  10.3.2 Global Plasma-derived Factor VIII Price (2013-2018)

11 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET SEGMENT BY APPLICATION

11.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
11.2 Hemophilia A Sales Growth (2013-2018)
11.3 Spontanous / Trauma Sales Growth (2013-2018)
11.4 Surgical Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)

12 HUMAN COAGULATION FACTOR VIII MARKET FORECAST (2018-2023)

12.1 Global Human Coagulation Factor VIII Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Coagulation Factor VIII Market Forecast by Regions (2018-2023)
  12.2.1 North America Human Coagulation Factor VIII Market Forecast (2018-2023)
  12.2.2 Europe Human Coagulation Factor VIII Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Human Coagulation Factor VIII Market Forecast (2018-2023)
  12.2.4 South America Human Coagulation Factor VIII Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Human Coagulation Factor VIII Market Forecast (2018-2023)
12.3 Human Coagulation Factor VIII Market Forecast by Type (2018-2023)
  12.3.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2018-2023)
  12.3.2 Global Human Coagulation Factor VIII Market Share Forecast by Type (2018-2023)
12.4 Human Coagulation Factor VIII Market Forecast by Application (2018-2023)
  12.4.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2018-2023)
  12.4.2 Global Human Coagulation Factor VIII Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Human Coagulation Factor VIII Picture
Table Product Specifications of Human Coagulation Factor VIII
Figure Global Sales Market Share of Human Coagulation Factor VIII by Types in 2017
Table Human Coagulation Factor VIII Types for Major Manufacturers
Figure Recombinant Factor VIII Picture
Figure Plasma-derived Factor VIII Picture
Figure Human Coagulation Factor VIII Sales Market Share by Applications in 2017
Figure Hemophilia A Picture
Figure Spontanous / Trauma Picture
Figure Surgical Picture
Figure Other Picture
Figure United States Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure France Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure UK Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure China Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure India Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Human Coagulation Factor VIII Revenue (Value) and Growth Rate (2013-2023)
Table Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxter) Human Coagulation Factor VIII Type and Applications
Table Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Human Coagulation Factor VIII Type and Applications
Table Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Human Coagulation Factor VIII Type and Applications
Table CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Human Coagulation Factor VIII Type and Applications
Table Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Human Coagulation Factor VIII Type and Applications
Table Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Human Coagulation Factor VIII Type and Applications
Table Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Human Coagulation Factor VIII Type and Applications
Table Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table NovoNordisk Basic Information, Manufacturing Base and Competitors
Table NovoNordisk Human Coagulation Factor VIII Type and Applications
Table NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Greencross Basic Information, Manufacturing Base and Competitors
Table Greencross Human Coagulation Factor VIII Type and Applications
Table Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Human Coagulation Factor VIII Type and Applications
Table Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Human Coagulation Factor VIII Type and Applications
Table BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Human Coagulation Factor VIII Type and Applications
Table Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RAAS Basic Information, Manufacturing Base and Competitors
Table RAAS Human Coagulation Factor VIII Type and Applications
Table RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Coagulation Factor VIII Sales by Manufacturer (2016-2017)
Figure Global Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2016
Figure Global Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2017
Table Global Human Coagulation Factor VIII Revenue by Manufacturer (2016-2017)
Figure Global Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2016
Figure Global Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2017
Figure Top 3 Human Coagulation Factor VIII Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Human Coagulation Factor VIII Manufacturer (Revenue) Market Share in 2017
Figure Global Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Global Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table Global Human Coagulation Factor VIII Sales by Regions (2013-2018)
Table Global Human Coagulation Factor VIII Sales Market Share by Regions (2013-2018)
Table Global Human Coagulation Factor VIII Revenue by Regions (2013-2018)
Figure Global Human Coagulation Factor VIII Revenue Market Share by Regions in 2013
Figure Global Human Coagulation Factor VIII Revenue Market Share by Regions in 2017
Figure North America Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Europe Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure South America Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure North America Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table North America Human Coagulation Factor VIII Sales by Countries (2013-2018)
Table North America Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
Figure North America Human Coagulation Factor VIII Sales Market Share by Countries in 2013
Figure North America Human Coagulation Factor VIII Sales Market Share by Countries in 2017
Table North America Human Coagulation Factor VIII Revenue by Countries (2013-2018)
Table North America Human Coagulation Factor VIII Revenue Market Share by Countries (2013-2018)
Figure North America Human Coagulation Factor VIII Revenue Market Share by Countries in 2013
Figure North America Human Coagulation Factor VIII Revenue Market Share by Countries in 2017
Figure United States Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Canada Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Mexico Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Europe Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table Europe Human Coagulation Factor VIII Sales by Countries (2013-2018)
Table Europe Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
Table Europe Human Coagulation Factor VIII Revenue by Countries (2013-2018)
Figure Europe Human Coagulation Factor VIII Revenue Market Share by Countries in 2016
Figure Europe Human Coagulation Factor VIII Revenue Market Share by Countries in 2017
Figure Germany Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure UK Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure France Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Russia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Italy Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Coagulation Factor VIII Sales by Countries (2013-2018)
Table Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Countries 2017
Table Asia-Pacific Human Coagulation Factor VIII Revenue by Countries (2013-2018)
Figure Asia-Pacific Human Coagulation Factor VIII Revenue Market Share by Countries 2017
Figure China Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Japan Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Korea Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure India Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Southeast Asia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure South America Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table South America Human Coagulation Factor VIII Sales by Countries (2013-2018)
Table South America Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
Figure South America Human Coagulation Factor VIII Sales Market Share by Countries in 2017
Table South America Human Coagulation Factor VIII Revenue by Countries (2013-2018)
Table South America Human Coagulation Factor VIII Revenue Market Share by Countries (2013-2018)
Figure South America Human Coagulation Factor VIII Revenue Market Share by Countries in 2017
Figure Brazil Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Argentina Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Colombia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Coagulation Factor VIII Sales by Countries (2013-2018)
Table Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Countries in 2017
Table Middle East and Africa Human Coagulation Factor VIII Revenue by Countries (2013-2018)
Table Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Countries in 2013
Figure Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure UAE Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Egypt Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure Nigeria Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Figure South Africa Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Table Global Human Coagulation Factor VIII Sales by Type (2013-2018)
Table Global Human Coagulation Factor VIII Sales Share by Type (2013-2018)
Table Global Human Coagulation Factor VIII Revenue by Type (2013-2018)
Table Global Human Coagulation Factor VIII Revenue Share by Type (2013-2018)
Figure Global Recombinant Factor VIII Sales Growth (2013-2018)
Figure Global Recombinant Factor VIII Price (2013-2018)
Figure Global Plasma-derived Factor VIII Sales Growth (2013-2018)
Figure Global Plasma-derived Factor VIII Price (2013-2018)
Table Global Human Coagulation Factor VIII Sales by Application (2013-2018)
Table Global Human Coagulation Factor VIII Sales Share by Application (2013-2018)
Figure Global Spontanous / Trauma Sales Growth (2013-2018)
Figure Global Surgical Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Human Coagulation Factor VIII Sales, Revenue and Growth Rate (2018-2023)
Table Global Human Coagulation Factor VIII Sales Forecast by Regions (2018-2023)
Table Global Human Coagulation Factor VIII Market Share Forecast by Regions (2018-2023)
Figure North America Sales Human Coagulation Factor VIII Market Forecast (2018-2023)
Figure Europe Sales Human Coagulation Factor VIII Market Forecast (2018-2023)
Figure Asia-Pacific Sales Human Coagulation Factor VIII Market Forecast (2018-2023)
Figure South America Sales Human Coagulation Factor VIII Market Forecast (2018-2023)
Figure Middle East and Africa Sales Human Coagulation Factor VIII Market Forecast (2018-2023)
Table Global Human Coagulation Factor VIII Sales Forecast by Type (2018-2023)
Table Global Human Coagulation Factor VIII Market Share Forecast by Type (2018-2023)
Table Global Human Coagulation Factor VIII Sales Forecast by Application (2018-2023)
Table Global Human Coagulation Factor VIII Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List